HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation.
McElrath
M J
MJ
Department of Medicine, University of Washington School of Medicine, Seattle 98144, USA.
Siliciano
R F
RF
Weinhold
K J
KJ
D016915:AIDS Vaccines / Q000276:immunology* / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D016915:AIDS Vaccines